Page 24 - துறை ஆஃப் மருந்தியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from துறை ஆஃப் மருந்தியல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In துறை ஆஃப் மருந்தியல் Today - Breaking & Trending Today

Central University of Punjab organized a Webinar on "Integrity in Scientific Research" and 'Zebrafish: A real time Experimental Model' – India Education| Global Education |Education News


Apr 18, 2021
Prof. S.S. Sharma, the first speaker, deliberated on the topic of “Integrity in Scientific Research: Guidelines and Strategies to Foster Integrity”. He discussed the misconduct in research like fabrication, falsification, plagiarism etc, and talked about the other forms of violations of good research practice like sale and purchase of articles, manipulating authorship, publishing in predatory journals, misuse of different materials etc. He talked about the role of International and Indian Agencies to foster integrity in research through plagiarism software and various digital libraries like Shodh Ganga, ORCHID.etc. He encouraged young researchers to follow the rules to ensures research ethics and focus on quality research work ....

Himachal Pradesh , Puneet Bansal , Damanpreet Singh , Shodh Ganga , Shyams Sharma , Raghavendrap Tiwari , Csir Institute Of Himalayan Bioresource Technology , Toxicology Laboratory , National Institute Of Pharmaceutical Education , Department Of Pharmacology , Possibilities In Biomedical Research , Biomedical Research , Integrity In Scientific Research , Pharmaceutical Sciences , Natural Products , Central University , Scientific Research , New Possibilities , Invited Speakers , Webinar Series , National Institute , Pharmaceutical Education , Senior Scientist , Himalayan Bioresource Technology , Indian Agencies , இமாச்சல் பிரதேஷ் ,

HKUMed discovers a novel mediator of liver fibrosis and its underlying mechanism that can be a new therapeutic target


Date Time
Share
HKUMed discovers a novel mediator of liver fibrosis and its underlying mechanism that can be a new therapeutic target
HKUMed discovers a novel mediator of liver fibrosis and its underlying mechanism that can be a new therapeutic target. The research was led by Dr Ruby Hoo Lai-chong (second from left), Assistant Professor, Department of Pharmacology and Pharmacy, HKUMed and Co-investigator of State Key Laboratory of Pharmaceutical Biotechnology, HKU. Dr Wu Xiaoping (second from right), post-doctoral fellow, Department of Pharmacology and Pharmacy, HKUMed is the first author. Other research team members include: Ms Zong Jiuyu (left) and Ms Zhang Zixuan (right), postgraduate student, Department of Pharmacology and Pharmacy, HKUMed. ....

United States , Hong Kong , Li Jingjing , Zong Jiuyu , Zhang Zixuan , Wang Cunchuan , Ruby Hoo Lai Chong , Shu Lingling , Wu Xiaoping , Health Bureau , Key Laboratory Of Pharmaceutical Biotechnology , University Of Hong Kong Hkumed , Research Grants Council , Department Of Medicine , Technology Program , Collaborative Research Fund , Professor Of Department Pharmacology , Drug Administration , Department Of Pharmacology , Guangdong Pharmaceutical University , Sun Yat Sen University Cancer Center , Research Program , Professor Of The Department Pharmacology , Health Medical Research Fund , First Affiliated Hospital Of Jinan University , Assistant Professor ,

Simulations Plus Inc (SLP) Q2 2021 Earnings Call Transcript


Simulations Plus Inc (SLP) Q2 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Simulations Plus Inc (NASDAQ: SLP)
Popular Searches
Operator
Greetings and welcome to Simulations Plus Second Quarter Fiscal 2021 Financial Results Conference Call and Webinar. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce Jeff Stanlis from HAYDEN IR. Thank you. Mr. Stanlis, you may now begin.SPONSORED:
10 stocks we like better than Simulations Plus, Inc. ....

United States , France General , Matt Hewitt , David Windley , Jeff Stanlis , Paul Watkins , Shawn Oconnor , Dilisym Renasym , Francois Brisebois , David Windley Jefferies , University Of North Carolina , Simulations Plus Inc , Translational Sciences , Brazilian Health Regulatory Agency , Motley Fool Simulations Plus Inc , Toxicological Research , University Of Pittsburgh Drug Discovery Institute , Francois Brisebois Oppenheimer Co , Renasym Consortium , Institute Of Pharmaceutical Sciences , National Center , Makerere University , Department Of Pharmacology , Exchange Commission , Matthew Hewitt Craig Hallum Capital Group , Health Canada ,